Insider Trading › ZIOP › Insiders
ZIOP
ZIOP·Insider activity
—
No end-of-day price on record
ZIOP
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
ZIOPS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
No open-market insider purchases or sales of ZIOP were filed in the last 180 days. Newest filing Dec 27, 2021 (4 years ago).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by ZIOP insiders · Form 4 · last two years
No open-market insider buys or sells in the last two years.
On Record
$0Purchases · 180 days
$0Sales · 180 days
55Open-market transactions on record
0Insiders filing · 180 days
Purchases (code P) and sales (code S) of ZIOP common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
55 on record · newest trade first
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| De Groot EleanorEVP, Operations | Sale | −20.1K | $1.27 | $26K | 237.1Kdirect | Dec 22, 2021 | Dec 27, 2021 | Form 4 ↗ |
| Boyle Kevin S. Sr.Chief Executive Officer · Director | Purchase | +9,116 | $1.40 | $13K | 885.0Kdirect | Nov 17, 2021 | Nov 17, 2021 | Form 4 ↗ |
| Boyle Kevin S. Sr.Chief Executive Officer · Director | Purchase | +884 | $1.40 | $1K | 875.9Kdirect | Nov 16, 2021 | Nov 17, 2021 | Form 4 ↗ |
| Vieser JaimeDirector | Purchase | +100.0K | $1.91 | $191K | 705.3Kdirect | Sep 29, 2021 | Oct 4, 2021 | Form 4 ↗ |
| Hagen HeidiDirector | Purchase | +23.8K | $1.76 | $42K | 145.9Kdirect | Sep 2, 2021 | Sep 3, 2021 | Form 4 ↗ |
| Postma Robert WDirector | Purchase | +54.5K | $1.73 | $94K | 4.3Mindirect | Sep 2, 2021 | Sep 3, 2021 | Form 4 ↗ |
| Postma Robert WDirector | Purchase | +20.5K | $1.73 | $35K | 1.2Mdirect | Sep 2, 2021 | Sep 3, 2021 | Form 4 ↗ |
| Weis HolgerDirector | Purchase | +50.0K | $1.83 | $92K | 120.2Kdirect | Sep 1, 2021 | Sep 3, 2021 | Form 4 ↗ |
| Huang JamesDirector | Purchase | +100.0K | $1.71 | $171K | 108.3Kdirect | Sep 1, 2021 | Sep 3, 2021 | Form 4 ↗ |
| Buck JillEVP, GM Gene Therapy | Sale | −27.9K | $3.12 | $87K | 199.5Kdirect | Jan 8, 2021 | Jan 12, 2021 | Form 4 ↗ |
| Lafond Kevin GSVP, Treasurer & CAO | Sale | −18.0K | $3.09 | $56K | 64.0Kdirect | Jan 8, 2021 | Jan 12, 2021 | Form 4 ↗ |
| Hadfield RobertGeneral Counsel and Secretary | Sale | −26.5K | $3.12 | $83K | 133.3Kdirect | Jan 8, 2021 | Jan 12, 2021 | Form 4 ↗ |
| De Groot EleanorEVP, GM Cell Therapy | Sale | −21.6K | $2.72 | $59K | 206.4Kdirect | Jan 4, 2021 | Jan 6, 2021 | Form 4 ↗ |
| Cooper Laurence James NeilPresident and CEO · Director | Sale | −105.7K | $2.71 | $286K | 1.8Mdirect | Jan 4, 2021 | Jan 6, 2021 | Form 4 ↗ |
| MAUNEY DAVID M MDPresident | Sale | −22.4K | $4.55 | $102K | 195.3Kdirect | Jan 2, 2020 | Jan 3, 2020 | Form 4 ↗ |
| Lafond Kevin GSVP, Treasurer & CAO | Sale | −21.6K | $4.55 | $98K | 64.0Kdirect | Jan 2, 2020 | Jan 3, 2020 | Form 4 ↗ |
| Hadfield RobertGeneral Counsel and Secretary | Sale | −16.9K | $4.55 | $77K | 100.7Kdirect | Jan 2, 2020 | Jan 3, 2020 | Form 4 ↗ |
| De Groot EleanorEVP, GM Cell Therapy | Sale | −24.9K | $4.55 | $113K | 174.3Kdirect | Jan 2, 2020 | Jan 3, 2020 | Form 4 ↗ |
| Buck JillEVP, GM Gene Therapy | Sale | −27.9K | $4.55 | $127K | 173.7Kdirect | Jan 2, 2020 | Jan 3, 2020 | Form 4 ↗ |
| Cooper Laurence James NeilChief Executive Officer · Director | Sale | −110.7K | $4.88 | $540K | 1.7Mdirect | Dec 30, 2019 | Dec 31, 2019 | Form 4 ↗ |
| Lafond Kevin GSVP, Treasurer & CAO | Sale | −11.7K | $5.25 | $61K | 85.6Kdirect | Nov 26, 2019 | Nov 27, 2019 | Form 4 ↗ |
| Cooper Laurence James NeilChief Executive Officer | Purchase | +6,440 | $4.68 | $30K | 1.1Mdirect | Nov 8, 2017 | Nov 9, 2017 | Form 4 ↗ |
| MAUNEY DAVID M MDEVP and Chief Business Officer | Purchase | +4,270 | $4.68 | $20K | 58.7Kdirect | Nov 8, 2017 | Nov 9, 2017 | Form 4 ↗ |
| BELBEL CAESAR JCOO, CLO, and Secretary | Sale | −153.3K | $12.84 | $2.0M | 59.2Kdirect | Nov 19, 2015 | Nov 23, 2015 | Form 4 ↗ |
| LEBEL FRANCOISExecutive Vice President R&D | Sale | −50.0K | $10.12 | $506K | 0direct | Jun 9, 2015 | Jun 11, 2015 | Form 4 ↗ |
| BRENNAN MURRAYDirector | Sale | −5,837 | $9.55 | $56K | 12.5Kdirect | Jun 4, 2015 | Jun 5, 2015 | Form 4 ↗ |
| Lafond Kevin GVice Pres., Treasurer, & CAO | Sale | −27.5K | $9.70 | $267K | 0direct | Jun 3, 2015 | Jun 5, 2015 | Form 4 ↗ |
| Lafond Kevin GVice Pres., Treasurer, & CAO | Sale | −3,334 | $9.70 | $32K | 0direct | Jun 3, 2015 | Jun 5, 2015 | Form 4 ↗ |
| Lafond Kevin GVice Pres., Treasurer, & CAO | Sale | −26.7K | $9.60 | $256K | 0direct | Jun 3, 2015 | Jun 5, 2015 | Form 4 ↗ |
| BRENNAN MURRAYDirector | Sale | −34.2K | $9.72 | $332K | 18.3Kdirect | Jun 3, 2015 | Jun 5, 2015 | Form 4 ↗ |
| INTREXON CORP10% owner | Purchase | +1.4M | $8.75 | $12.6M | 17.8Mindirect | Feb 9, 2015 | Feb 10, 2015 | Form 4 ↗ |
| INTREXON CORP10% owner | Purchase | +2.9M | $3.50 | $10.0M | 16.4Mindirect | Oct 29, 2013 | Oct 31, 2013 | Form 4 ↗ |
| KIRK RANDAL JDirector · 10% owner | Purchase | +3.6M | — | — | 13.5Mindirect | Nov 7, 2012 | Nov 9, 2012 | Form 4 ↗ |
| KIRK RANDAL JDirector · 10% owner | Purchase | +1.9M | $5.20 | $10.0M | 9.9Mindirect | Jan 20, 2012 | Jan 23, 2012 | Form 4 ↗ |
| INTREXON CORP10% owner | Purchase | +38.3K | $4.99 | $191K | 1.3Mindirect | Aug 23, 2011 | Aug 25, 2011 | Form 4 ↗ |
| KIRK RANDAL JDirector · 10% owner | Purchase | +110.8K | $4.91 | $544K | 1.3Mindirect | Aug 22, 2011 | Aug 22, 2011 | Form 4 ↗ |
| KIRK RANDAL JDirector · 10% owner | Purchase | +197.4K | $4.91 | $969K | 1.2Mindirect | Aug 19, 2011 | Aug 22, 2011 | Form 4 ↗ |
| KIRK RANDAL JDirector · 10% owner | Purchase | +153.5K | $4.95 | $760K | 1.0Mindirect | Aug 18, 2011 | Aug 22, 2011 | Form 4 ↗ |
| Fowler WycheDirector | Purchase | +5,000 | $5.19 | $26K | 72.5Kdirect | Aug 10, 2011 | Aug 11, 2011 | Form 4 ↗ |
| INTREXON CORP10% owner | Purchase | +285.5K | $5.13 | $1.5M | 846.5Kindirect | Aug 9, 2011 | Aug 9, 2011 | Form 4 ↗ |
| INTREXON CORP10% owner | Purchase | +444.9K | $4.58 | $2.0M | 561.0Kindirect | Aug 8, 2011 | Aug 9, 2011 | Form 4 ↗ |
| INTREXON CORP10% owner | Purchase | +116.1K | $4.65 | $540K | 116.1Kindirect | Aug 5, 2011 | Aug 9, 2011 | Form 4 ↗ |
| WEISER MICHAELDirector | Sale | −15.0K | $6.53 | $98K | 135.9Kdirect | May 25, 2011 | May 26, 2011 | Form 4 ↗ |
| BRENNAN MURRAYDirector | Sale | −15.0K | $6.57 | $99K | 52.5Kdirect | May 9, 2011 | May 11, 2011 | Form 4 ↗ |
| KIRK RANDAL JDirector · 10% owner | Purchase | +1.9M | $5.75 | $11.0M | 8.0Mindirect | Feb 3, 2011 | Feb 7, 2011 | Form 4 ↗ |
| INTREXON CORP10% owner | Purchase | +3.6M | — | — | 6.1Mindirect | Jan 12, 2011 | Jan 14, 2011 | Form 4 ↗ |
| INTREXON CORP10% owner | Purchase | +2.4M | $4.80 | $11.6M | 2.4Mindirect | Jan 12, 2011 | Jan 14, 2011 | Form 4 ↗ |
| CANNON JAMES ANTHONYDirector | Purchase | +175.0K | $3.10 | $543K | 220.0Kdirect | Dec 9, 2009 | Dec 11, 2009 | Form 4 ↗ |
| MCINERNEY TIMOTHYDirector | Purchase | +50.0K | $3.10 | $155K | 208.2Kdirect | Dec 9, 2009 | Dec 11, 2009 | Form 4 ↗ |
| ESSEX WOODLANDS HEALTH VENTURES FUND VI L P10% owner | Purchase | +129.0K | $3.10 | $400K | 2.4Mdirect | Dec 8, 2009 | Dec 10, 2009 | Form 4 ↗ |
| ESSEX WOODLANDS HEALTH VENTURES FUND VI L P10% owner | Purchase | +328.8K | $1.83 | $602K | 2.2Mdirect | Sep 15, 2009 | Dec 10, 2009 | Form 4 ↗ |
| MCINERNEY TIMOTHYDirector | Purchase | +50.0K | $1.83 | $92K | 128.2Kdirect | Sep 15, 2009 | Sep 17, 2009 | Form 4 ↗ |
| LEWIS JONATHANCEO · Director | Purchase | +3,000 | $3.00 | $9K | 5,000direct | Dec 7, 2007 | Dec 10, 2007 | Form 4 ↗ |
| MCINERNEY TIMOTHYDirector | Purchase | +4,000 | $5.00 | $20K | 63.2Kdirect | Mar 15, 2007 | Mar 22, 2007 | Form 4 ↗ |
| LEWIS JONATHANCEO · Director | Purchase | +2,000 | $4.95 | $10K | 2,000direct | Mar 12, 2007 | Mar 14, 2007 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →